26 jan: Villa Joy - dansk konceptbolig med verdensinspiration og potentia..
02 feb: Stort behov for mini-MBA i bestyrelsesuddannelse
28-01-2010 08:02:00

Preliminary Annual Accounts / Fourth Quarter Report 2009

This information is subject of the disclosure requirements acc. to §5-12 vphl

(Norwegian Securities Trading Act)

Rieber & Søn's operating profit (EBIT) in the fourth quarter totalled NOK 185m

(122m), while the figure for the year was NOK 424m (356m). EPS in the fourth

quarter stood at  NOK 1.52  (0.82) and NOK 3.32 (2.46) for the year.

Sales in the fourth quarter came to NOK 1 256m (1 377m), while the figure for

the year was NOK 4 967m (4 997m). Structural effects had a negative effect on

sales, reducing the performance by 1.6% in the fourth quarter, and by 0.6% for

the year. Currency conversion effects reduced sales in the fourth quarter by

4.7% and by 0.4% for the year. Organic growth stood at -2.4% in the fourth

quarter, while the increase for the year was 0.4%.

The gross margin in the fourth quarter rose to 59.2% (57.1%) and to 56.7%

(56,0%) for the year. The Group had good cost control in the fourth quarter and

payroll and operating costs were down 8% at NOK 569m, while the figure for the

year was 1% lower at NOK 2 218m. The EBITDA margin for the fourth quarter was

13,9% (12.1%) and 12.1% (11.2%) for the year. The corresponding figures for

 EBIT margin were 14.7% (8.9%) and 8.5% (7.1%), respectively.

The operating profit in the fourth quarter was positively affected by one-off

effects which contributed NOK 61m. This was the net effect of income of NOK 77m

from the sale of the  Sopps brand and the marine ingredients line in Arna, and

costs of NOK 16m related to the write-down of the production plant for Anja Cake

in Poland and transaction costs for the acquisition of Gellwe which was not

approved by the Polish competition authorities.  The operating profit for the

year was positively affected by one-off effects totalling NOK 32m. The Group's

core activities exclusive one-off items provided EPS of NOK 3.09 for the year,

which was 30% up on 2008.

The return on capital employed was 22.7% (14.1%) in the fourth quarters and

12.8% (10.9%) for the year.

In line with the Group's dividend policy, the Board will ask the AGM to approve

a dividend of NOK 2.00 per share. Together, this represents a 60% increase in

the dividend compared with the previous year and a dividend ratio of 60%.

"Our Future"

"Our Future" is aimed at achieving lasting improvements in results of NOK 400m

in 2012. The extra consumption of resources of a one-time nature in order to

realise these improvements is estimated to cost NOK 125m. The programme is

progressing as planned.

In the fourth quarter, the net effect of improvements in purchasing, production

and marketing under the "Our Future" platform totalled NOK 35m and comprised

positive effects of NOK 44m in the fourth quarter and implementation costs of

NOK 9m. The accumulated total of the positive, lasting effects in the first 12

months was NOK 96m, while implementation costs in the same period came to NOK

47m.

The aim to improve Group profitability was achieved in line with the plans for

2009. Through good cost control and the implementation of efficiency programmes

which provide lasting improvements, a sound basis has been laid for further

growth in profitability.

Bergen, 27 January 2010

Board of Directors of Rieber & Søn ASA

[HUG#1377906]

4Q Quarter Report 2009 : http://hugin.info/121/R/1377906/338577.pdf

4Q Presentation 2009: http://hugin.info/121/R/1377906/338578.pdf

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
21 apr
PNDORA
Du er dødbringende for EI, Goodwrench. Man gider snart ikke læse med mere, når du forurener/destruer..
31
25 apr
PNDORA
Her er de aktier der har min opmærksomhed... Bemærk en gang iskoldt overblik og common sense er i sp..
29
24 apr
BAVA
  Tirsdag 25/4 generalforsamling Torsdag den 4/5 Q1 regnskab   Vi har den 1/5 om fire børsdage, ge..
18
20 apr
 
EU skal tilbage til en handels afale landene imellem, glem alt omfaelles regering,faelles valuta og ..
18
23 apr
PNDORA
  Det meste tyder i mine øjne på, at Pandora showet fortsætter næste uge med nye fald.       Jeg ove..
17
22 apr
 
Manden kommer med noget helt reelt, som kan diskuteres. I stedet bliver der svaret på sædvanlig EI ..
17
25 apr
 
Den stenrige Baron lå for døden. Men han nåede at få solgt alle sine aktier og lavede en aftale med ..
16
23 apr
OMXC25
Har i bemærket, at de skribenter, der skriver de værste svinere, har fået flest grønne tommelfingre?..
16
21 apr
PNDORA
Jeg har netop fået email fra ABG om at Maverick har trukket følehornene til sig. Short-præsentatione..
16
20 apr
 
Ja lad os få lukket grænser igen i europa, forhindre handel og gøre det meget mere besværlig.    Lad..
15

Novo-rival har succes med diabetespille og spår yderligere vækst

27-04-2017 13:39:31
Novo Nordisks svensk-britiske konkurrent Astrazeneca har markant fremgang med sin diabetespille, Farxiga, og spår midlet en generelt lovende fremtid.I første kvartal voksede salget af Farxiga med 25 pct. i lokal valuta til 207 mio. dollar.- SGLT-2-klassen vandt markedsandele fra andre former for medicin mod type 2-diabetes, og det har også potentiale til at tage yderligere markedsandele baseret på..

Mærsk: Havnerival oplevede stor vækst i havnene i første kvartal

27-04-2017 09:27:54
Der blev skruet op for hastigheden på havnekajene verden over for DP World i første kvartal.Havneselskabet med hovedsæde i Dubai oplevede en organisk vækst på 5,0 pct. i gennemløbet af containere i de havne, hvor selskabet har aktiviteter og ejerandele. Det ligger dermed på næsten det dobbelte af Drewrys estimat om 2,6 pct. vækst i containermarkedet i samme kvartal, bemærker selskabet.Ser man på t..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Novo-rival har succes med diabetespille og spår yderligere vækst
2
Aktier/tendens: Nordea og Dong til eksamen efter regnskaber - NY
3
Nets mobile dankort ligger klar i App Store
4
Svensk kuglelejeproducent til vejrs i Stockholm efter stærkt regnskab
5
Torsdagens aktier: Novo sparkede det danske marked i ny rekord

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
27. april 2017 18:51:19
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: ReleaseCandidateBuild_20170427.1 - EUROWEB5 - 2017-04-27 18:51:19 - 2017-04-27 18:51:19 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x